In a Time of Crisis: Dr. Amanda Rischbieth on Blood Donation, Solidarity, and Saving Lives
Dr Amanda Rischbieth, Harvard Advanced Leadership Advisory Board at Harvard University, shared a post on LinkedIn:
“With my Chair of the National Blood Authority, Australia hat on, I thank the thousands who have stepped up without hesitation.
As of 1pm today, Australian Red Cross Lifeblood service has seen 20,000 appointments booked nationally and many waited up to 5hr to give blood.
So much healing ahead yet we are seeing such unwaivering spirit, love and support for those impacted yesterday at Bondi, in Sydney.
My heartfelt condolences to those who have lost loved ones, those who are injured, and the entire Jewish community in Sydney and beyond.
O negative and O positive blood are always in high demand because they are used in emergency situations when a patient’s blood type is unknown.
Fewer than 7% of the population are O negative so in particular we need O negative donors to donate.
With gratitude to all donors and emergency responders/hospital workers/blood donation teams, and NBA workers side by side with Red Cross in moving blood to where its most needed and fast ramping up donation capability.”
Get the latest hemostasis insights on Hemostasis Today.
-
Mar 16, 2026, 17:12Cold-Stored vs Room-Temperature Platelets in Trauma-Induced Coagulopathy – JTH
-
Mar 16, 2026, 17:10Arturo Cesaro: First Meta-Analysis on the Vascular Protective Role of Semaglutide in PAD
-
Mar 16, 2026, 17:01Jeff Sternlicht: The Most Powerful Time to Lower Cholesterol Is Before Anyone Thinks You Need It
-
Mar 16, 2026, 16:14Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk
-
Mar 16, 2026, 16:12Nuha El Sayed: Focused Summary of the 2026 ACC/AHA Guideline on Management of Dyslipidemia in Diabetes
-
Mar 16, 2026, 16:08Deepak Sudheendra: When a Vascular Looking Skin Pattern Isn’t Vascular
-
Mar 16, 2026, 16:06Surendra Karki։ Examining Blood Type and Coronary Heart Disease Risk in Australian Donors
-
Mar 16, 2026, 15:58Alan Nurden: Genome-Wide Analyses Unravel the Genetic Architecture of Coagulation and Fibrinolysis
-
Mar 16, 2026, 15:56Emmanuel J. Favaloro: Latest Publication from Sydney Centres on Heparin Therapy and Monitoring